Table 3

Number of patients receiving non-pharmacological antispasticity treatment

 INCOCON
 First 3 study months (n=108)Last 3 study months (n=94)First 3 study months (n=110)Last 3 study months (n=84)
Physiotherapy60 (56%)51 (54%)68 (62%)52 (62%)
Occupational therapy43 (40%)44 (47%)15 (14%)8 (10%)
Speech therapy10 (9%)9 (9%)5 (5%)4 (5%)
Others3 (3%)4 (4%)3 (3%)1 (1%)
  • Data are number of patients (%). Multiple responses permitted.

  • CON, patients receiving conventional therapy; INCO, patients receiving incobotulinumtoxinA.